Business Briefs: Knee, Obesity Approvals, And A Deal Roundup
This article was originally published in The Gray Sheet
Key approvals for Stryker and Apollo Endosurgery, and deals by Boston Scientific, Illumina, Abbott and Lombard Medical.
You may also be interested in...
Obesity device firm Apollo Endosurgery and drug firm LPath Inc. have announced plans to merge in an agreement that is intended to transition the privately held Apollo into a NASDAQ-listed company.
Insulin device firm CeQur and liquid biopsy firm Exosome Diagnostics closed financing rounds; Abbott completes its transcatheter mitral valve replacement deal; Unilife considers its options; and Quest Diagnostics subsidiary advances infectious disease offerings.
A media report stating Abbott was readying to buy St. Jude Medical was quickly shot down by the company. The firms do, though, have relatively complementary product portfolios